<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://localhost:8080/xmlui/handle/123456789/727">
<title>Book Chapters</title>
<link>http://localhost:8080/xmlui/handle/123456789/727</link>
<description>Published Book Chapters from the department.</description>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://localhost:8080/xmlui/handle/123456789/2092"/>
</rdf:Seq>
</items>
<dc:date>2026-04-06T00:46:40Z</dc:date>
</channel>
<item rdf:about="http://localhost:8080/xmlui/handle/123456789/2092">
<title>Evaluation of Some Liver Enzymes in HIV/AIDS Patients on Antiretroviral Therapy in University of Abuja Teaching Hospital, Nigeria</title>
<link>http://localhost:8080/xmlui/handle/123456789/2092</link>
<description>Evaluation of Some Liver Enzymes in HIV/AIDS Patients on Antiretroviral Therapy in University of Abuja Teaching Hospital, Nigeria
ABRIBA, Simon P.; GAMBE, Solomom M.; CHINDO, Ezekiel
Background: Hepatoxicity is a major complication and side effect of antiretroviral therapy (ART).&#13;
Unfortunately, such studies in this area of evaluating the adverse drug reaction of ART on the liver&#13;
hepatocytes are only few in number in Nigeria. Objective: To determine the levels of some liver&#13;
enzymes in HIV/AIDS patients on antiretroviral therapy (ART) and as well evaluate their impact on&#13;
liver hepatocytes. Methods: This is a hospital-based case-control study. A total of 153 subjects were&#13;
recruited in the study, and they were divided into three groups: the control group (which consist of&#13;
apparently healthy subjects), the study group 1 (consist of HIV positive subject not on ART), and&#13;
study group 2 (consist of HIV/AIDS patients on ART). The liver enzymes Alanine amino Transferase&#13;
(ALT), Asparate amino Transfarase (AST) and Alkaline Phosphatase (ALP) were determined using&#13;
enzyme linked spectrophotometric assay methods, according to the manufacturer’s specifications.&#13;
Results: The mean standard deviation (SD) of ALT and AST activity of the study group 1 showed&#13;
significant differences when compared with that of the control group P&lt;0.001, but the ALP has no&#13;
significant differences P&gt;0.05. In Study group 2, (HIV/AIDS patients on ART) showed significant&#13;
differences of P&lt;0.001 in ALT, AST and ALP. Conclusion: Some liver enzymes were elevated in&#13;
subjects on antiretroviral therapy; this elevation could be due to hepatotoxicity of the (ART) used&#13;
by the HIV/AIDS patients on the liver hepatocytes.
</description>
<dc:date>2024-04-02T00:00:00Z</dc:date>
</item>
</rdf:RDF>
